Document is current
Any future updates will be listed below
-
Authors
Abudu, Mufeez
Asafu-Adjaye, Andy
Osei, Joseph Harold Nyarko
Frempong, Kwadwo Kyereme
Akuoko, Osei Kwaku
Pi-Bansa, Sellase
Ofei, Mavis
Boakye, Helena Anokyewaa
Ansah-Owusu, Jane
Arkorful, Sandra-Candys Adwirba
Asigbaase, Michelle Ayuritolya
Tawiah-Mensah, Christopher Nii Laryea
Greco, Beatrice
Manteau, Delalih
Jesus, Thalita
Oppong, Daniel
Mahler, Andy
Boakye, Daniel Adjei
Dadzie, Samuel Kweku
- License Information
-
More Information
Article History
Received: 10 February 2025
Accepted: 8 July 2025
First Online: 7 October 2025
Declarations
:
: Ethical approval for the study was sought from the Scientific and Technical Committee and the Institutional Review Board (IRB) of the Noguchi Memorial Institute for Medical Research. All safety issues for the repellent were fully considered. The study was approved on 17 July 2023 by the NMIMR-IRB with approval no. NMIMR-IRB CPN 001/23-24. All vector collectors agreed to be part of the study and signed a consent form. Vector collectors were also trained. Arrangements were made to report any adverse events to the nearest hospital in the testing area for treatment according to the national guidelines for malaria treatment. Free treatment was offered to vector collectors as a requirement for ethical approval. Any protocol amendments and/or deviations were documented, fully justified, and maintained with the protocol. All protocol amendments were approved by the study director, and the sponsor was informed.
: All authors gave their consent for the publication.
: The authors declare no competing interests.
